Literature DB >> 22142405

The response of human ectomesenchymal dental pulp stem cells to cisplatin treatment.

M Seifrtová1, R Havelek, J Cmielová, A Jiroutová, T Soukup, L Brůčková, J Mokrý, D English, M Rezáčová.   

Abstract

AIM: To determine the response of dental pulp stem cells (DPSCs) to DNA-damaging cytostatic cisplatin and compare it with the response of normal human dermal fibroblasts (HDFs).
METHODOLOGY: Dental pulp stem cells were exposed to 5, 10, 20 or 40 μmol L(-1) of cisplatin. The proliferation of affected cells was assessed by a Z2 Counter and viability was assessed by means of a Vi-Cell XR using Trypan blue exclusion staining. Cell cycle analysis and induction of apoptosis were performed by flow cytometry. Induction of apoptosis was determined by monitoring the activities of caspases. The expression of proteins was detected by electrophoresis and Western blotting. The descriptive statistics of the results was analyzed by Student's t-test.
RESULTS: Dental pulp stem cells had a greater genotoxic stress response to cisplatin compared to HDFs. All three main Mitogen-activated protein kinases (MAPK) families - extracellular signal-regulated kinases (ERK), c-Jun-N-terminal kinase (JNK) and p38 were activated after treatment of DPSCs with cisplatin. The activation of MAPK pathways was not observed in HDFs exposed to cisplatin. The exposure of DPSCs and HDFs to cisplatin provoked an increase in p53 and p21 expression and p53 phosphorylation of serine 15. Higher concentrations of cisplatin reduced the viability of DPSCs and HDFs and induced the activation of caspases 3/7 and 9.
CONCLUSION: Dental pulp stem cells had a greater genotoxic stress response to cisplatin compared to HDFs. Cisplatin in higher concentrations triggered activation of MAPK and apoptosis in DPSCs but not in HDFs.
© 2011 International Endodontic Journal.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22142405     DOI: 10.1111/j.1365-2591.2011.01990.x

Source DB:  PubMed          Journal:  Int Endod J        ISSN: 0143-2885            Impact factor:   5.264


  14 in total

Review 1.  Signalling mechanisms involved in renal pathological changes during cisplatin-induced nephropathy.

Authors:  Siddesh Jaiman; Arun Kumar Sharma; Kulwant Singh; Deepa Khanna
Journal:  Eur J Clin Pharmacol       Date:  2013-08-09       Impact factor: 2.953

Review 2.  Molecular mechanisms and cardiovascular implications of cancer therapy-induced senescence.

Authors:  Ibrahim Y Abdelgawad; Karim T Sadak; Diana W Lone; Mohamed S Dabour; Laura J Niedernhofer; Beshay N Zordoky
Journal:  Pharmacol Ther       Date:  2020-12-01       Impact factor: 12.310

Review 3.  Human mesenchymal stem cells - current trends and future prospective.

Authors:  Imran Ullah; Raghavendra Baregundi Subbarao; Gyu Jin Rho
Journal:  Biosci Rep       Date:  2015-04-28       Impact factor: 3.840

4.  Epigallocatechin gallate does not accelerate the early phase of liver regeneration after partial hepatectomy in rats.

Authors:  Vojtěch Mezera; Otto Kučera; Alena Moravcová; Eva Peterová; Zuzana Červinková
Journal:  Dig Dis Sci       Date:  2013-12-08       Impact factor: 3.199

Review 5.  Mesenchymal Stem Cells Subpopulations: Application for Orthopedic Regenerative Medicine.

Authors:  Vanessa Pérez-Silos; Alberto Camacho-Morales; Lizeth Fuentes-Mera
Journal:  Stem Cells Int       Date:  2016-09-20       Impact factor: 5.443

Review 6.  Mesenchymal stem cells: amazing remedies for bone and cartilage defects.

Authors:  Parisa Kangari; Tahereh Talaei-Khozani; Iman Razeghian-Jahromi; Mahboobeh Razmkhah
Journal:  Stem Cell Res Ther       Date:  2020-11-23       Impact factor: 6.832

Review 7.  Human Mesenchymal Stem Cells: The Present Alternative for High-Incidence Diseases, Even SARS-Cov-2.

Authors:  Karen J Juárez-Navarro; Eduardo Padilla-Camberos; Néstor Fabián Díaz; Ariel Miranda-Altamirano; N Emmanuel Díaz-Martínez
Journal:  Stem Cells Int       Date:  2020-12-18       Impact factor: 5.443

8.  Clinical Risk Factors Influencing Dental Developmental Disturbances in Childhood Cancer Survivors.

Authors:  Chung-Min Kang; Seung Min Hahn; Hyo Sun Kim; Chuhl Joo Lyu; Jae-Ho Lee; Jinae Lee; Jung Woo Han
Journal:  Cancer Res Treat       Date:  2017-10-10       Impact factor: 4.679

Review 9.  Application of Mesenchymal Stem Cells in Inflammatory and Fibrotic Diseases.

Authors:  Jae-Sung Ryu; Eun-Jeong Jeong; Jong-Yeup Kim; Soon Ju Park; Won Seok Ju; Chang-Hyun Kim; Jang-Seong Kim; Young-Kug Choo
Journal:  Int J Mol Sci       Date:  2020-11-07       Impact factor: 5.923

Review 10.  Comparison of similar cells: Mesenchymal stromal cells and fibroblasts.

Authors:  Burcu Ugurlu; Erdal Karaoz
Journal:  Acta Histochem       Date:  2020-10-12       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.